Table 2 Return to initial α-blocker among patients taking a second α-blocker.
Year medication/treatment started | Initiating α-blocker | Third α-blocker | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tamsulosin (n, %) | Alfuzosin (n, %) | Silodosin (n, %) | Doxazosin (n, %) | Terazosin (n, %) | Return rate‡ (n, %) | ||||||||
2002–3 | Tamsulosin | — | — | 40 | 9.7% | 131 | 31.8% | 96 | 23.3% | 145 | 35.2% | ||
Alfuzosin | 20 | 27.0% | — | — | 13 | 17.6% | 24 | 32.4% | 17 | 23.0% | |||
Silodosin | — | — | — | — | |||||||||
Doxazosin | 157 | 27.9% | 49 | 8.7% | — | — | 200 | 35.5% | 157 | 27.9% | |||
Terazosin | 311 | 37.9% | 63 | 7.7% | 220 | 26.8% | — | — | 227 | 27.6% | |||
2005–6 | Tamsulosin | — | — | 145 | 23.7% | 128 | 20.9% | 117 | 19.1% | 223 | 36.4% | ||
Alfuzosin | 82 | 52.9% | — | — | 26 | 16.8% | 22 | 14.2% | 25 | 16.1% | |||
Silodosin | — | — | — | — | |||||||||
Doxazosin | 149 | 45.3% | 53 | 16.1% | — | — | 54 | 16.4% | 73 | 22.2% | |||
Terazosin | 189 | 41.4% | 62 | 13.6% | 90 | 19.7% | — | — | 115 | 25.2% | |||
2009–10 | Tamsulosin | — | — | 199 | 22.2% | 133 | 14.9% | 151 | 16.9% | 157 | 17.5% | 255 | 28.5% |
Alfuzosin | 127 | 47.0% | — | — | 21 | 7.8% | 41 | 15.2% | 28 | 10.4% | 53 | 19.6% | |
Silodosin | 66 | 51.2% | 19 | 14.7% | — | — | 17 | 13.2% | 11 | 8.5% | 16 | 12.4% | |
Doxazosin | 127 | 42.8% | 46 | 15.5% | 29 | 9.8% | — | — | 43 | 14.5% | 52 | 17.5% | |
Terazosin | 151 | 42.1% | 42 | 11.7% | 30 | 8.4% | 54 | 15.0% | — | — | 82 | 22.8% | |
